These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Kinetic and clinical studies on a new cephalosporin: Cefotiam]. Soranzo ML, Capra E, Eandi M, Bosio G, Salassa B, Bendiscioli L, Bramato C, Musso E, Andreoni G, Morelli B, Fabiano A, Di Nola F, Misto P. Minerva Med; 1982 Oct 13; 73(39):2671-8. PubMed ID: 6289193 [Abstract] [Full Text] [Related]
5. [Clinical evaluation of cefotiam in adults urinary tract infections (author's transl)]. Guibert J, Coppens H, Yvelin C. Pathol Biol (Paris); 1982 Jun 13; 30(6):353-6. PubMed ID: 6287388 [Abstract] [Full Text] [Related]
6. [Clinical laboratory approach for determination of effective dose of cefotiam. Observation from disc susceptibility test and MICs]. Uete T, Tsuzaki Y, Furukawa S, Matsuo K. Jpn J Antibiot; 1982 Jun 13; 35(6):1441-61. PubMed ID: 6290707 [Abstract] [Full Text] [Related]
7. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties. Matsumoto K, Nagatake T, Uzuka Y, Harada T, Rikitomi N. Chemotherapy; 1983 Jun 13; 29(2):80-8. PubMed ID: 6301776 [Abstract] [Full Text] [Related]
9. [Bacteriological in vitro studies with a new cephalosporin: cefotiam (author's transl)]. Grimm H. Arzneimittelforschung; 1981 Jun 13; 31(11):1867-9. PubMed ID: 6274364 [Abstract] [Full Text] [Related]
11. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams]. Reynaud A, Desnoes M, Derriennic M, Courtieu AL. Pathol Biol (Paris); 1985 May 13; 33(5):313-9. PubMed ID: 3929216 [Abstract] [Full Text] [Related]
12. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin]. Husson MO, Izard D, Leclerc H. Pathol Biol (Paris); 1985 Jun 13; 33(5 Pt 2):466-8. PubMed ID: 3911141 [Abstract] [Full Text] [Related]
13. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin. Mini E, Mazzei T, Periti P, Reali EF, Bordonaro P, Balocchini E, Ninu B. Chemioterapia; 1987 Apr 13; 6(2):95-8. PubMed ID: 3594635 [Abstract] [Full Text] [Related]
14. [Laboratory and clinical studies of cefotiam in digestive diseases]. Kanoh H, Sakakibara K, Nukuta N, Mizokami M, Ninomiya N, Katoh T, Tokuda Y, Izuchi K, Yamashita Y, Kawamura T. Jpn J Antibiot; 1984 Feb 13; 37(2):209-18. PubMed ID: 6330390 [Abstract] [Full Text] [Related]
15. [On the clinical effects of cefotiam on acute cystitis and changes in form of E. coli in the urine]. Washida H, Tsugaya M, Hirao N, Hachisuka Y, Takeuchi K, Inuzuka K. Hinyokika Kiyo; 1983 Oct 13; 29(10):1373-80. PubMed ID: 6100419 [Abstract] [Full Text] [Related]
16. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime]. Le Noc P, Bryskier A, Le Noc D. Pathol Biol (Paris); 1985 May 13; 33(5):399-403. PubMed ID: 3897972 [Abstract] [Full Text] [Related]
18. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers]. Bryskier A, Humbert G, Borsa F, Bertrand A, Janbon F, Lafaix C, Beucler A, Veyssier P, Dusehu E, Modai J. Pathol Biol (Paris); 1983 May 13; 31(5):328-35. PubMed ID: 6312392 [Abstract] [Full Text] [Related]
19. [Comparative evaluation of the antibacterial activity of cefotaxime and cephalotin by using an automated antimicrobial susceptibility determination system]. Concia E, Marone P, Dos Santos C, Bono L. Quad Sclavo Diagn; 1982 Jun 13; 18(2):223-32. PubMed ID: 6300953 [Abstract] [Full Text] [Related]
20. [Clinical experience with cefotiam in the field of pediatrics (author's transl)]. Takashima Y, Hatano T, Tauchi N, Maki T, Uozumi K, Kawamura M. Jpn J Antibiot; 1981 May 13; 34(5):651-4. PubMed ID: 6270404 [Abstract] [Full Text] [Related] Page: [Next] [New Search]